Volume 18 Number 10

This is the dedicated PCR London Valves edition with debates on key issues in the management of valvular disease and articles on the critical role played by evaluating coronary artery disease (CAD) in predicting unplanned percutaneous coronary interventions (PCI) after transcatheter aortic valve replacement (TAVR); TAVR and the incidence of paravalvular aortic regurgitation (AR) using the new ACURATE neo2; comparing percutaneous vascular closure strategies after TAVI using either Dual ProGlide vs ProGlide and FemoSeal, a combination of suture-based with plug-based vascular closure devices approach; the management of deteriorated mitral bioprostheses using either transcatheter valve-in-valve implantation or redo surgical mitral valve replacement; a new surgical procedure for extracardiac annuloplasty using the BACE (Basal Annuloplasty of the Cardia Externally) device; using historic data from surgical tricuspid valve replacement (TVR) studies as a benchmark for the development of tricuspid valve replacement (TTVR) trials; the impact of RV-pulmonary artery (PA) coupling on clinical outcomes of tricuspid regurgitation in patients undergoing mitral transcatheter edge-to-edge repair (TEER); first in human use of the Topaz transcatheter tricuspid valve replacement device; and more...